These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1727 related articles for article (PubMed ID: 33956667)

  • 21. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2.
    Majdoubi A; Michalski C; O'Connell SE; Dada S; Narpala S; Gelinas J; Mehta D; Cheung C; Winkler DF; Basappa M; Liu AC; Görges M; Barakauskas VE; Irvine M; Mehalko J; Esposito D; Sekirov I; Jassem AN; Goldfarb DM; Pelech S; Douek DC; McDermott AB; Lavoie PM
    JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33720905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    Walsh EE; Frenck RW; Falsey AR; Kitchin N; Absalon J; Gurtman A; Lockhart S; Neuzil K; Mulligan MJ; Bailey R; Swanson KA; Li P; Koury K; Kalina W; Cooper D; Fontes-Garfias C; Shi PY; Türeci Ö; Tompkins KR; Lyke KE; Raabe V; Dormitzer PR; Jansen KU; Şahin U; Gruber WC
    N Engl J Med; 2020 Dec; 383(25):2439-2450. PubMed ID: 33053279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations.
    Efrati S; Catalogna M; Abu Hamad R; Hadanny A; Bar-Chaim A; Benveniste-Levkovitz P; Levtzion-Korach O
    Sci Rep; 2021 Aug; 11(1):16543. PubMed ID: 34400714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 26. SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection.
    Kang YM; Choe KW; Lee KD; Kim KN; Kim MJ; Lim J
    J Korean Med Sci; 2021 Sep; 36(35):e250. PubMed ID: 34490757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers.
    Rovida F; Cassaniti I; Paolucci S; Percivalle E; Sarasini A; Piralla A; Giardina F; Sammartino JC; Ferrari A; Bergami F; Muzzi A; Novelli V; Meloni A; Cutti S; Grugnetti AM; Grugnetti G; Rona C; Daglio M; Marena C; Triarico A; Lilleri D; Baldanti F
    Nat Commun; 2021 Oct; 12(1):6032. PubMed ID: 34654808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine.
    Ragone C; Meola S; Fiorillo PC; Penta R; Auriemma L; Tornesello ML; Miscio L; Cavalcanti E; Botti G; Buonaguro FM; Bianchi A; Buonaguro L; Tagliamonte M
    Front Immunol; 2021; 12():734689. PubMed ID: 34386018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
    de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
    Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
    Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L
    Front Immunol; 2021; 12():697074. PubMed ID: 34262569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
    Del Poeta G; Bomben R; Polesel J; Rossi FM; Pozzo F; Zaina E; Cattarossi I; Varaschin P; Nanni P; Boschian Boschin R; Postorino M; Laureana R; Pasqualone G; Steffan A; Gentile M; Zucchetto A; Gattei V
    Hematol Oncol; 2021 Dec; 39(5):712-714. PubMed ID: 34462939
    [No Abstract]   [Full Text] [Related]  

  • 33. Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine.
    Marc GP; Alvarez-Paggi D; Polack FP
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 34018969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: Erratum.
    Transplantation; 2024 May; 108(5):e77. PubMed ID: 38659118
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19.
    Parums DV
    Med Sci Monit; 2021 Dec; 27():e935624. PubMed ID: 34848673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021.
    Subbarao S; Warrener LA; Hoschler K; Perry KR; Shute J; Whitaker H; O'Brien M; Baawuah F; Moss P; Parry H; Ladhani SN; Ramsay ME; Brown KE; Amirthalingam G
    Euro Surveill; 2021 Mar; 26(12):. PubMed ID: 33769252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses to SARS-CoV-2 vaccines in neuromuscular disorders may depend on their etiology and current drug treatment.
    Finsterer J
    Rev Neurol (Paris); 2024 May; 180(5):470-471. PubMed ID: 38311527
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vaccine response to SARS-CoV-2 in hospital workers].
    Sabater Vidal S; Bellido-Cambrón MC; Arnedo-Pena A; Palomares-Gallego MI; Larrea-González RM; Carballido-Fernández M; Moreno-Muñoz R
    Arch Prev Riesgos Labor; 2021 Oct; 24(4):383-403. PubMed ID: 34965327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.
    Megasari NLA; Khairunisa SQ; Arizandy RY; Wijaksana IKE; Wungu CDK
    PeerJ; 2024; 12():e17257. PubMed ID: 38646483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adequate Antibody Response to COVID-19 Vaccine in Patients with Monoclonal Gammopathies and Light Chain Amyloidosis.
    Wu AHB; Wang CC; Ong CM; Lynch KL
    Lab Med; 2022 May; 53(3):314-319. PubMed ID: 35026018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 87.